Mercado global de ART de tecnologia reprodutiva assistida – Tendências do setor e previsão para 2031

Análise e tamanho do mercado de ART de tecnologia de reprodução assistida

O mercado da Tecnologia de Reprodução Assistida (TARV) está a registar um crescimento significativo, impulsionado por fatores como o aumento das taxas de infertilidade, os avanços na tecnologia e a crescente consciencialização e aceitação dos procedimentos de TARV. O mercado é caracterizado por um aumento do número de casais que procuram tratamentos de infertilidade, juntamente com uma tendência crescente para o atraso na parentalidade. Além disso, fatores como a crescente prevalência de condições como a síndrome dos ovários policísticos (SOP) e a endometriose , que podem contribuir para a infertilidade, estão a impulsionar o crescimento do mercado. Além disso, a disponibilidade de vários procedimentos de TARV, como a fertilização in vitro (FIV), a injeção intracitoplasmática de espermatozóides (ICSI) e a barriga de aluguer, está a expandir as opções para os casais que procuram engravidar.

O tamanho global do mercado da tecnologia de reprodução assistida ART foi avaliado em 28,49 mil milhões de dólares em 2023 e deverá atingir os 54,32 mil milhões de dólares até 2031, com um CAGR de 8,4% durante o período de previsão de 2024 a 2031. Além dos insights sobre cenários de mercado como o valor de mercado, taxa de crescimento, segmentação, cobertura geográfica e grandes players, os relatórios de mercado com curadoria da Data Bridge Market Research também incluem análises especializadas aprofundadas, epidemiologia de pacientes, análise de pipeline , análise de preços e enquadramento regulamentar.

Âmbito do relatório e segmentação de mercado       

Market Definition

Assisted Reproductive Technology (ART) refers to a range of medical procedures used to treat infertility. ART involves the manipulation of eggs, sperm, or embryos to help achieve pregnancy. Common ART procedures include in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and gamete intrafallopian transfer (GIFT). Assisted reproductive technologies (ARTs) are usually used to treat infertility when other methods of achieving pregnancy, such as medication or surgery, have not been successful. 

Assisted Reproductive Technology ART Market Dynamics

Drivers

• Increasing Infertility Rates

The prevalence of infertility is on the rise globally, fueled by various factors such as lifestyle changes, environmental factors, and age-related fertility issues. Modern lifestyles characterized by stress, unhealthy diet, and sedentary habits have contributed to hormonal imbalances and reproductive health issues, leading to an increase in infertility cases. Environmental factors such as exposure to pollutants and toxins can also negatively impact fertility. In addition, age-related fertility issues become more prevalent, with more couples choosing to start families later in life. These factors combined have led to a growing demand for ART procedures, driving market growth.    

• Delayed Parenthood   

Delayed parenthood has become increasingly common, driven by factors such as pursuing higher education, establishing careers, and financial stability. Many individuals and couples choose to delay starting a family until later in life, often in their 30s or even 40s. Although delaying parenthood offers benefits such as emotional maturity and financial security, it also presents challenges related to fertility. As individuals age, the quality and quantity of their eggs and sperm decrease, making conception more challenging. This has contributed to a growing demand for ART procedures among older individuals, as they seek assistance in overcoming age-related fertility issues and realizing their goal of starting a family, driving the market growth.

Opportunities

• Growing Awareness and Acceptance

There has been a significant increase in awareness about infertility treatments, with more individuals and couples seeking solutions to overcome fertility challenges. This growing awareness has been accompanied by a shift in societal attitudes towards ART, with more acceptance and understanding of these treatments as viable options for achieving pregnancy. As a result, there has been a notable increase in the number of couples seeking ART procedures. In addition, the recognition of male infertility as a significant factor in couples' inability to conceive has further fueled research and development efforts toward innovative treatments for male factor infertility, expanding the market opportunities.  

• Technological Advancements in ART  

There are continuous advancements in infertility art-assisted reproductive technology, leading to improved treatment outcomes and expanded options for patients. Technologies such as improved embryo culture techniques, genetic testing, and embryo selection methods have significantly enhanced the success rates of ART procedures. These advancements in embryo culture techniques have enhanced the monitoring and selection of embryos with the highest likelihood of successful implantation, thereby improving the overall success rates of IVF procedures. Similarly, genetic testing has enabled the screening of embryos for genetic abnormalities, reducing the risk of miscarriage and improving the chances of a successful pregnancy. These technological advancements have not only improved the effectiveness of ART procedures but have also expanded the treatment options available to patients, driving market growth.

Restraints/Challenges

• High Cost of ART Procedures 

The expenses involved in ART can quickly add up, making it unaffordable for some individuals and couples. Factors contributing to the high cost of ART include the need for specialized medical equipment, laboratory procedures, and highly trained personnel. In addition, the cost of medications used in ART can be substantial, especially for hormone treatments required to stimulate ovulation. The financial burden of ART can be further exacerbated by the fact that success is not guaranteed, and multiple treatment cycles may be needed before achieving a successful pregnancy, leading to additional costs. As a result, the high cost of ART procedures remains a major challenge for many individuals and couples seeking infertility treatment. 

• Health Risks in ART procedures

ART procedures can carry health risks for both the mother and the child, which need to be carefully considered before undergoing treatment. One of the primary risks associated with ART is the increased likelihood of multiple pregnancies, which can result in complications such as premature birth, low birth weight, and other health issues for both the mother and the babies.  Women who undergo ART procedures face the risk of developing ovarian hyperstimulation syndrome (OHSS), which is characterized by enlarged and painful ovaries. While OHSS is usually mild, severe cases can lead to complications such as fluid buildup in the abdomen and chest, blood clots, and kidney failure. While assisted reproductive technology is an infertility treatment, the potential health risks associated with these procedures can be a challenge for market.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the assisted reproductive technology market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In July 2021, Hamilton Throne Ltd., a worldwide leader in ART research, completed the acquisition of IVFTECH ApS (IVFtech) and its affiliated company, K4 Technology ApS. IVFtech specializes in supplying laminar flow workstations and high-capacity incubators for ART, leveraging the expertise of its affiliated firm, K4. The transaction was valued at USD 8 million
• In September 2020, Assisted Reproductive Technology ART bill was introduced in Lok Sabha. the Bill aims to regulate Assisted Reproductive Technology (ART) services in India. ART encompasses all techniques that aim to achieve pregnancy by manipulating sperm or oocytes outside the body and transferring the gamete or embryo into a woman's reproductive system. Instances of ART services include gamete donation, in-vitro fertilisation (fertilising an egg in a lab), and gestational surrogacy (where the child is not biologically related to the surrogate mother). ART services will be provided through ART clinics, which offer related treatments and procedures, and ART banks, which store and supply gametes

Assisted Reproductive Technology ART Market Scope

The market is segmented on the basis of procedure, technology, product type, and end-use. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Procedure

• Fresh Donor
• Fresh Nondonor
• Frozen Donor
• Frozen Nondonor
• Embryo/Egg Banking

Technology

• In-vitro Fertilization (IVF)
  • IVF with Intracytoplasmic Sperm Injection (ICSI)
  • IVF without ICSI
• Artificial Insemination - Intrauterine Insemination (AI-IUI)
• Frozen Embryo Replacement (FER)
• Surrogacy
• Ovulation Induction
• Others

 Product Type

• Women Younger Than Age 35
• Women Older Than Age 35

 End Use

• Hospitals
• Fertility Clinics
• Others

Assisted Reproductive Technology ART Market Regional Analysis/Insights

The market is analyzed and market size insights and trends are provided by country, procedure, technology, product type, and end-use as referenced above.

The countries covered in the market are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, and Rest of South America.

North America is expected to dominate the market due to a combination of rising infertility rates and a heightened awareness of available fertility treatments. The region's well-established healthcare infrastructure, coupled with high disposable income, enables greater access to and adoption of ART procedures. In addition, the presence of leading ART clinics and research facilities further helps the market growth in the region.

Asia-Pacific is expected to witness significant growth during the forecast period due to several factors, including the increasing trend of late family planning adoption, where couples are choosing to have children at a later age, leading to a higher demand for ART services. Moreover, the relatively lower costs of ART treatments in the Asia-Pacific region compared to other parts of the world make these services more accessible to a broader population. The region's improving healthcare infrastructure and advancements in ART technologies also contribute to its growth.

A secção do país do relatório também fornece fatores individuais de impacto no mercado e alterações na regulamentação do mercado interno que impactam as tendências atuais e futuras do mercado. Pontos de dados como a análise da cadeia de valor a jusante e a montante, tendências técnicas e análise das cinco forças de Porter, estudos de caso são alguns dos indicadores utilizados para prever o cenário de mercado para países individuais. Além disso, são considerados a presença e disponibilidade de marcas globais e os desafios enfrentados devido à grande ou escassa concorrência de marcas locais e nacionais, o impacto das tarifas nacionais e das rotas comerciais, ao mesmo tempo que se fornece uma análise de previsão dos dados do país.

Base instalada de crescimento da infraestrutura de saúde e penetração de novas tecnologias

O mercado de tecnologia de reprodução assistida ART também fornece análises de mercado detalhadas para o crescimento de cada país em termos de despesas de saúde para equipamentos de capital, base instalada de diferentes tipos de produtos para o mercado de tecnologia de reprodução assistida ART, impacto da tecnologia utilizando curvas de linha de vida e alterações na regulamentação de saúde cenários e o seu impacto no mercado da tecnologia de reprodução assistida ART. Os dados estão disponíveis para o período histórico 2016-2021.

Análise do cenário competitivo e tecnologia de reprodução assistida ART Market Share

O cenário competitivo do mercado fornece detalhes por concorrente. Os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em investigação e desenvolvimento, novas iniciativas de mercado, presença global, localizações e instalações de produção, capacidades de produção, pontos fortes e fracos da empresa , lançamento de produto, largura e amplitude do produto, aplicação domínio. Os dados acima fornecidos estão apenas relacionados com o foco das empresas em relação ao mercado.

Alguns dos principais players que operam no mercado são:

• Cryobank da Califórnia (EUA)
• Centro de Fertilidade Bloom (Índia)
• Anecova (Suíça)
• CooperSurgical (EUA)
• Merck KGaA (Alemanha)
• Ferring BV (Suíça)
• FUJIFILM Irvine Scientific (EUA)
• Genea Limited (Austrália)
• Nidacon International AB (Suécia)
• Celmatix, Lda.
• Esco Micro Pte Ltd. (Singapura)
• INVO Biociências (EUA)
• Laboratório CCD (França)
• Nikon Instruments Inc.
• (EUA)

SKU-51909